Phibro Animal Health Reports Record Fiscal Year 2026 Results
Phibro Animal Health Corporation (PAHC) reported strong financial results for fiscal year 2026, with record net sales exceeding $1.5 billion and a significant increase in adjusted EBITDA of 39% to $255 million. The fourth quarter saw continued growth, with sales up 5% and adjusted EBITDA rising by 29%. CEO Dani Bendheim highlighted the company's improved execution, operational efficiency, and long-term positioning for growth. The Mineral Nutrition segment performed particularly well in both Q4 (up 20%) and full-year results (11%), driven by a diverse customer base across species and markets. The Animal Health business remains central to Phibro’s strategy as the primary driver of future expansion.
Tickers: $PAHC
Topics: 2026 Financial Performance Phibro Animal Health Q4 Earnings Call